265 related articles for article (PubMed ID: 27330931)
1. Monitoring Allergen Immunotherapy Effects by Microarray.
Lupinek C; Wollmann E; Valenta R
Curr Treat Options Allergy; 2016; 3():189-203. PubMed ID: 27330931
[TBL] [Abstract][Full Text] [Related]
2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
[TBL] [Abstract][Full Text] [Related]
3. Heterogenous Induction of Blocking Antibodies against Ragweed Allergen Molecules by Allergen Extract-Based Immunotherapy Vaccines.
Zbîrcea LE; Buzan MR; Grijincu M; Cotarcă MD; Tamaș TP; Haidar L; Tănasie G; Huțu I; Babaev E; Stolz F; Valenta R; Păunescu V; Panaitescu C; Chen KW
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932364
[TBL] [Abstract][Full Text] [Related]
4. Novel vaccines for allergen-specific immunotherapy.
Akinfenwa O; Rodríguez-Domínguez A; Vrtala S; Valenta R; Campana R
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):86-99. PubMed ID: 33369572
[TBL] [Abstract][Full Text] [Related]
5. Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber S; Lang R; Steiner M; Aglas L; Ferreira F; Wallner M; Hawranek T; Gadermaier G
Clin Transl Allergy; 2018; 8():39. PubMed ID: 30338052
[TBL] [Abstract][Full Text] [Related]
6. Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy.
Thörnqvist L; Sjöberg R; Greiff L; van Hage M; Ohlin M
Front Allergy; 2022; 3():859126. PubMed ID: 35769580
[TBL] [Abstract][Full Text] [Related]
7. Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy.
Fukano C; Ohashi-Doi K; Lund K; Nakao A; Masuyama K; Matsuoka T
J Pharmacol Sci; 2019 Jul; 140(3):223-227. PubMed ID: 31353210
[TBL] [Abstract][Full Text] [Related]
8. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
Vizzardelli C; Gindl M; Roos S; Möbs C; Nagl B; Zimmann F; Sexl V; Kenner L; Neunkirchner A; Zlabinger GJ; Pickl WF; Pfützner W; Bohle B
Allergy; 2018 Apr; 73(4):851-861. PubMed ID: 29159964
[TBL] [Abstract][Full Text] [Related]
9. Microarray-Based Allergy Diagnosis: Quo Vadis?
Huang HJ; Campana R; Akinfenwa O; Curin M; Sarzsinszky E; Karsonova A; Riabova K; Karaulov A; Niespodziana K; Elisyutina O; Fedenko E; Litovkina A; Smolnikov E; Khaitov M; Vrtala S; Schlederer T; Valenta R
Front Immunol; 2020; 11():594978. PubMed ID: 33679689
[TBL] [Abstract][Full Text] [Related]
10. Autologous enzyme-linked immunosorbent facilitated antigen binding detects IgE-blocking activity based on direct competition between allergen-specific IgE and non-IgE.
Zhong H; Lai X; Li J; Xiao X; Chen S; Würtzen PA
Immunotherapy; 2021 Nov; ():. PubMed ID: 34816749
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.
Pajno GB; Bernardini R; Peroni D; Arasi S; Martelli A; Landi M; Passalacqua G; Muraro A; La Grutta S; Fiocchi A; Indinnimeo L; Caffarelli C; Calamelli E; Comberiati P; Duse M;
Ital J Pediatr; 2017 Jan; 43(1):13. PubMed ID: 28257631
[TBL] [Abstract][Full Text] [Related]
12. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
13. IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
Russkamp D; Aguilar-Pimentel A; Alessandrini F; Gailus-Durner V; Fuchs H; Ohnmacht C; Chaker A; de Angelis MH; Ollert M; Schmidt-Weber CB; Blank S
Allergy; 2019 Aug; 74(8):1549-1560. PubMed ID: 30829405
[TBL] [Abstract][Full Text] [Related]
14. Past, present, and future of allergen immunotherapy vaccines.
Dorofeeva Y; Shilovskiy I; Tulaeva I; Focke-Tejkl M; Flicker S; Kudlay D; Khaitov M; Karsonova A; Riabova K; Karaulov A; Khanferyan R; Pickl WF; Wekerle T; Valenta R
Allergy; 2021 Jan; 76(1):131-149. PubMed ID: 32249442
[TBL] [Abstract][Full Text] [Related]
15. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
17. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
Ciprandi G; Tosca MA; Silvestri M
Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
[TBL] [Abstract][Full Text] [Related]
18. Use of biologics in allergen immunotherapy.
Pfützner W; Schuppe M
Allergol Select; 2021; 5():108-118. PubMed ID: 33634221
[TBL] [Abstract][Full Text] [Related]
19. Allergen Immunotherapy (AIT): a prototype of Precision Medicine.
Canonica GW; Bachert C; Hellings P; Ryan D; Valovirta E; Wickman M; De Beaumont O; Bousquet J
World Allergy Organ J; 2015; 8(1):31. PubMed ID: 26594303
[TBL] [Abstract][Full Text] [Related]
20. Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy.
Möbs C; Müller J; Rudzio A; Pickert J; Blank S; Jakob T; Spillner E; Pfützner W
Allergy; 2015 Jun; 70(6):715-9. PubMed ID: 25753563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
